DAFTAR PUSTAKA

1. American Cancer Society Guideline for Colorectal Cancer Screening. Accessed at:

https://www.cancer.org/content/dam/cancer-org/cancer-control/en/booklets-

flyers/summary-for-clinicians-acs-guideline-for-colorectal-cancer-screening.pdf

2. American Cancer Society. Colorectal Cancer Fact and Figures 2011-2013. Atlanta: American

Cancer Society, 2011.

3. Andrew,Wolf MD, Fontham E,et al.Colorectal Cancer Screening for Average Risk Adults:2018

Guideline Update from The American Society of Cancer.A Cancer Journal for

Clinician;2018;68(4).

4. Andus, T., Geiger, T., Hirano, T., Kishimoto, T., Tran-Thi, T.A., Decker, K. et al. (1988)

Regulation of synthesis and secretion of major rat acute-phase proteins by recombinant human

interleukin-6 (BSF-2/1L-6) in hepatocyte primary cultures. Eur. J. Biochem. 173, 287–293

5. Armelao F, Pretis G. Familial Colorectal Cancer: A Review. World Journal of

Gastroenterology,2014;20(28);9292-9298

6. Ashizawa T, Okada R,Suzuki Y,et al.Study of Interleukin-6 in the Spread of Colorectal Cancer :

The Diagnostic Significance of IL-6.Acta Med Okoyama.2006:60(6),p325-330

7. Baily R, Billingham R, Stamos M, et al. Anatomy and Physiology Colon and Rectum. In:

Colorectal Surgery. Philladelphia:Elsevier;2013.p3-15

8. Barresi V, Reggiani L, Leni A, Caruso R. Histological Grading in Colorectal

Cancer.Pubmed;May 2015. Accessed at:

https://www.researchgate.net/publication/277144456_Histological_grading_in_colorectal_cance

r_New_insights_and_perspectives

9. Basir I, Budiman R, Lusikoy R, et al. Panduan Penatalaksaan Kanker

Kolorektal.Jakarta:Perhimpunan Bedah Digestif Indonesia.IKABDI;2017

10. Bazan, J.F. (1990) Haemopoietic receptors and helical cytokines. Immunol. Today 11, 350–354
11. Belluco Claudia,Nitti Donato,Toppan Paola,et al. Interleukin-6 Blood Level is Associated with

Circulating Carcinoembryonic Antigen and Prognosis in Patient With Colorectal Cancer.Annals

of Surgical Oncology.2000;7(1):p.133-138

12. Benjia Liang, Leping Li, Ruizheng Miao, Jinshen Wang, Yuezhi Chen, Zequn Li, Xueqing Zou

& Mingliang Zhou. Expression of Interleukin-6 and Integrin 6 in Colon Cancer. 2019. Cancer

Investigation;37(3);p.174-184

13. Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T.B., Oukka, M. et al. (2006) Reciprocal

developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.

Nature 441, 235–238

14. Bland K, Buchler M, Csendes A, et al. Principle and International Practice General Surgery.

London: Springer; 2010

15. Buskermelon M, Cenin D, Helsingen L, et al. Colorectal Cancer Screening with Fecal

Immunochemical testing, Sigmoidoscopy or colonoscopy.British Medical Journal.2019;367.

16. Charles B, Andersen Dana, Billiar T, et al. Schwatz Principle of Surgery.

Philladelphia:McGrawHill;2019

17. Cho E, Smith-Warner SA, Spiegelman D, Beeson WL, van den Brandt PA, Colditz GA, et al.

Dairy foods, calcium, and colorectal cancer: a pooled analysis of 10 cohort studies. J Natl Cancer

Inst. 2004;96:1015-22.

18. Collins JF, Lieberman DA, Durbin TE. Weiss DG. Accuracy of screening for fecal occult blood

on a single stool sample obtained by digital rectal examination: a comparison with recommended

sampling practice. Ann Intern Med. 2005;142:81-5.

19. Fahrizal Maradjabessy, Laurens Kalesaran, Fery Kalitouw. Hubungan Nilai Carcinoembryonic

Antigen dengan Kejadian Metastasis Karsinoma Kolorektal di RSUP Prof. Dr. R. D. Kandou

Manado. Jurnal Biomedik.2018;10(1);p49-54.

20.Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: Sources,

methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136: E359–E386.
21. Gauldie, J., Richards, C., Harnish, D., Lansdorp, P. and Baumann, H. (1987) Interferon β 2/B-

cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating

factor and regulates the major acute phase protein response in liver cells. Proc. Natl Acad. Sci.

U.S.A. 84, 7251–7255

22. Glund, S., Deshmukh, A., Long, Y.C., Moller, T., Koistinen, H.A., Caidahl, K. et al. (2007)

Interleukin-6 directly increases glucose metabolism in resting human skeletal muscle. Diabetes

56, 1630–1637

23. Gordon P, Nivatvongs S, et al. Surgical anatomy and Physiology of Colon, Rectum and Anus.

In:Principles and Practice of Surgery for the Colon, Rectum and Anus.New York:Informa Health

Care;2007;p.2-61

24.Hibi M, Murakami M, Saito M, Hirano T, Taga T and Kishimoto T: Molecular cloning and

expression of an IL-6 signal transducer, gp130. Cell (1990) 63: 1149-1157

25. Hirano, T. (2014) Revisiting the 1986 molecular cloning of interleukin 6. Front. Immunol. 5, 456

26. Hirano, T., Taga, T., Matsuda, T., Hibi, M., Suematsu, S., Tang, B. et al. (1990) Interleukin 6

and its receptor in the immune response and hematopoiesis. Int. J. Cell Cloning 8, 155–167

27. Hirano, T., Taga, T., Yasukawa, K., Nakajima, K., Nakano, N., Takatsuki, F. et al. (1987)

Human B-cell differentiation factor defined by an anti-peptide antibody and its possible role in

autoantibody production. Proc. Natl Acad. Sci. U.S.A. 84, 228–231

28. Itoh, N., Matsuda, T., Ohtani, R. and Okamoto, H. (1989) Angiotensinogen production by rat

hepatoma cells is stimulated by B cell stimulatory factor 2/ interleukin-6. FEBS Lett. 244, 6–10

29. Ji, C., Chen, X., Gao, C., Jiao, L., Wang, J., Xu, G. et al. (2011) IL-6 induces lipolysis and

mitochondrial dysfunction, but does not affect insulin-mediated glucose transport in 3T3-L1

adipocytes. J. Bioenerg. Biomembr. 43, 367–375

30. Kanda, T. and Takahashi, T. (2004) Interleukin-6 and cardiovascular diseases. Jpn Heart J. 45,

183–193
31. Kim, J., Bachmann, R.A. and Chen, J. (2009) Interleukin-6 and insulin resistance. Vitam. Horm.

80, 613–633

32. Kishimoto, T., Hirano, T., Kuritani, T., Yamamura, Y., Ralph, P. and Good, R.A. (1978)

Induction of IgG production in human B lymphoblastoid cell lines with normal human T cells.

Nature 271, 756–758

33. Levin B, Lieberman DA, McFarland B, Smith RA, Brooks D, Andrews KS, et al. Screening and

surveillance for the early detection of colorectal cancer and adenomatous polyps: a joint

guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal

Cancer, and the American College of Radiology. CA Cancer J Clin. 2008; 58: 130-60.

34.Lukas F. Mager , Marie Wasmer, et al.Cytokine-induced Modulation of Colorectal Cancer. Front.

Oncol. 2016:6(6):p96-102.

35. Mager L, Rau T, Kreppe P, et all. Cytokine induced Modulation of Colorectal Cancer. Journal

frontiers of Oncology. 2016; 96(6): 1-19

36. Martin R Weiser. AJCC 8th edition : Colorectal Cancer. Ann Surg Oncol,2018;25:1454-1455

37. Mulholland M, Lillemoe K, Doherty G, et al. Scientific Principles and Practice

Surgery.Philladelpia:Lippincott Williams and Wilkin;2011

38. National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines

in Oncology. Colon Cancer Version 4.2019. 2019 Nov 8; National Comprehensive

Cancer Network. Available from URL: http://www.tri-

kobe.org/nccn/guideline/colorectal/ english/ colon.pdf

39. Niedermaier T, Weigl K, Hoffmeister M, Brenner H. Flexible Sigmoidoscopy in Colorectal

Cancer Screening. European Journal of Epidemiology,2018;33:473-484

40. Papanicolaou, D.A. (2000) Interleukin-6: the endocrine cytokine. J. Clin. Endocrinol. Metab. 85,

1331–1333
41. Rohleder, N., Aringer, M. and Boentert, M. (2012) Role of interleukin-6 in stress, sleep, and

fatigue. Ann. N. Y. Acad. Sci. 1261, 88–96

42.Siegel R, Jemal A, Cancer Statistic 2014. CA Cancer J Clin. 2014;64:9-29

43. Siegel R, Kimberly M, Jemal Ahmedin. Cancer Statistic. CA Cancer J Clin 2019;69:p27-34.

44. Taga, T., Hibi, M., Hirata, Y., Yamasaki, K., Yasukawa, K., Matsuda, T. et al. (1989)

Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell

58, 573–581

45. Tanaka, T., Narazaki, M. and Kishimoto, T. (2014) IL-6 in inflammation, immunity, and disease.

Cold Spring Harb. Perspect. Biol. 6, a016295

46. Townsend C, Beauchamp D, et al. Sabiston Textbook of Surgery.Philladelpia: Elsevier; 2017

47. Vieugels JL, Van Lanschoot MC, Dekker E. Colorectal Cancer Screening by Colonoscopy.Dig

Endosc,2016;28(3);250-9

48. Waldner M, Foersch S, Neurath M. Interleukin 6- A Key Regulator of Colorectal Cancer

Development. International Journal of Biological Sciences. 2012; 8(9): 1248-1253

49. Waldner M, Foersch S, Neurath M. Interleukin 6- A Key Regulator of Colorectal Cancer

Development. International Journal of Biological Sciences. 2012; 8(9): 1248-1253

50. Wang Zhen, Wu Pin, et al.Prognostic and clinicopathological significance of serum interleukin-6

expression in colorectal cancer: a systematic review and meta-analysis. Oncology Target and

Therapy. 2015; 3793-3801

51. Wolff B, Fleshman J, Beck D, et al. The ASCRS Textbook of Colon and Rectal

Surgery.London:Springer;2007

52. Yamagishi, Kuroda H, Imai Y, Hirashi H. Molecular Pathogenesis of Sporadic Colorectal

Cancer. Chin J Cancer, 2016;35:4

53. Budiono Bernadus, Then Joni, Istiadi Hermawan. Perbedaan Kadar Serum CEA dalam deteksi

Kanker Kolorektal dan Rekurensi Lokal di RSUP DR KARIADI. Ristekdikti:Jakarta;2018

54. Tzu Chi Hsu, Chi-Hsin Lin, et al. Postoperative Serum Levels of Interleukin-6 are Affected by

Age in Patient with Colorectal Cancer.International Journal of Gerontology,2017;11(2);75-79

55. Tatsuto Ashizawa, Ryosuke Okada, Yoshiaki Suzuki, Makoto Takagi, et al. Study of Interleukin-

6 in the Spread of Colorectal Cancer : The Diagnostic Significance of IL-6 . Acta Med

Okayama,2006;60(6), 325-330,